Abiopharma

News list

(70% Positive) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Clinical Development Update (Form 6-K)

Full text

News bot Oct. 18, 2025, 5:31 p.m.
🌍 ObsEva SA (company was delisted NASDAQ) (OBSV) - Form 6-K Filing

Filing Date: 2022-06-17

Accepted: 2022-06-17 07:05:30

Event Type: Clinical Trial Update

Event Details:

The EC decision follows confirmation of a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency in April 2022, and is valid in all 27 European Union Member States, as well as Iceland, Norway, and Liec.
💼 Business Developments:
- ✅ Partnership/Collaboration
- ❌ Acquisition Activity: Not reported
- ✅ Licensing Agreement
- ✅ Regulatory Milestone
- ❌ Leadership Updates: Not reported
📞 Contact Information:
- Investor Contact: Katja Buhrer katja.buhrer@obseva.com +1 (917) 969-3438 1. Stewart E, ASRM 2020;
- Email: shauna.dillon@obseva.ch